Rapeseed oil fortified with micronutrients improves cognitive alterations associated with metabolic syndrome

• Published in: Brain, behavior, and immunity behavior, and immunity, 2020-02, Vol.84, p.23-35
• Main Authors: Fourrier, Célia, Kropp, Camille, Aubert, Agnès, Sauvant, Julie, Vaysse, Carole, Chardigny, Jean-Michel, Layé, Sophie, Joffre, Corinne, Castanon, Nathalie
• Format: Article
• Language: English
• Subjects: Animal genetics; Animals; Antioxidants; Anxiety; Cognition - drug effects; Cognition Disorders - complications; Cognition Disorders - diet therapy; Cognition Disorders - physiopathology; Db/db mice; Disease Models, Animal; Food, Fortified; Genetics; Glutamatergic receptors; Hippocampus; Inflammation; Life Sciences; Male; Memory; Metabolic syndrome; Metabolic Syndrome - complications; Metabolic Syndrome - diet therapy; Metabolic Syndrome - physiopathology; Mice; Micronutrients - pharmacology; n-3 PUFAS; Obesity; Rapeseed Oil - chemistry; Rapeseed Oil - pharmacology
• ISSN: 0889-1591; 1090-2139
• DOI: 10.1016/j.bbi.2019.11.002

•n-3 PUFA/AO intake increased brain n-3 PUFA levels in a MetS model, the db/db mice.•n-3 PUFA/AO reversed hippocampus-dependent spatial memory deficits in db/db mice.•n-3 PUFA/AO modulated subunit composition of glutamate receptors in the hippocampus.•n-3 PUFA/AO may reduce MetS-related memory deficits by changing neuronal plasticity. Metabolic syndrome represents a major risk factor for severe comorbidities such as cardiovascular diseases or diabetes. It is also associated with an increased prevalence of emotional and cognitive alterations that in turn aggravate the disease and related outcomes. Identifying therapeutic strategies able to improve those alterations is therefore a major socioeconomical and public health challenge. We previously reported that both hippocampal inflammatory processes and neuronal plasticity contribute to the development of emotional and cognitive alterations in db/db mice, an experimental model of metabolic syndrome that displays most of the classical features of the syndrome. In that context, nutritional interventions with known impact on those neurobiological processes appear as a promising alternative to limit the development of neurobiological comorbidities of metabolic syndrome. We therefore tested here whether n-3 polyunsaturated fatty acids (n-3 PUFAs) associated with a cocktail of antioxidants can protect against the development of behavioral alterations that accompany the metabolic syndrome. Thus, this study aimed: 1) to evaluate if a diet supplemented with the plant-derived n-3 PUFA α-linolenic acid (ALA) and antioxidants (provided by n-3 PUFAs-rich rapeseed oil fortified with a mix of naturally constituting antioxidant micronutrients, including coenzyme Q10, tocopherol, and the phenolic compound canolol) improved behavioral alterations in db/db mice, and 2) to decipher the biological mechanisms underlying this behavioral effect. Although the supplemented diet did not improve anxiety-like behavior and inflammatory abnormalities, it reversed hippocampus-dependent spatial memory deficits displayed by db/db mice in a water maze task. It concomitantly changed subunit composition of glutamatergic AMPA and NMDA receptors in the hippocampus that has been shown to modulate synaptic function related to spatial memory. These data suggest that changes in local neuronal plasticity may underlie cognitive improvements in db/db mice fed the supplemented diet. The current findings might therefore provide valuable data for introducing